加速阶段的CML: de novo和转变的
Naranie Shanmuganathan1,2,3,4, Timothy P Hughes1,2,3
1Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, Australia.
Hematology. American Society of Hematology. Education Program
|December 9, 2023
概括
治疗晚期慢性髓性白血病 (CML) 仍然具有挑战性. 新的基因组洞察力和组合疗法为爆发期CML (BP-CML) 提供了希望,但对于高风险患者需要进一步研究.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 慢性髓性白血病 (CML) 的结果有所改善,但晚期,如爆发期CML (BP-CML),仍然有不良的预后.
- 高血压-CML是罕见的,但不太了解和治疗不充分,需要专注于预防疾病进展.
研究的目的:
- 审查当前对BP-CML管理的理解和挑战.
- 突出基因组研究的进展和BP-CML的新疗法策略.
- 解决需要改善高风险CML患者的鉴定和治疗的需求.
主要方法:
- 审查CML基因组学和治疗学的最新进展.
- 讨论诊断挑战,包括区分CML类ALL和淋巴状BP-CML.
- 探索新的治疗方法,如MATCHPOINT战略.
主要成果:
- 基因组研究显示,对BP-CML生物学的理解有限.
- "类似CML"ALL的概念有助于区分BCR::ABL1阳性ALL与新发性淋巴性BP-CML.
- 新型组合疗法显示出潜力,但需要进一步验证.
结论:
- 防止从慢性阶段的CML进展到BP-CML仍然是主要的治疗目标.
- 进一步的研究对于澄清高风险BP-CML患者的鉴定和治疗策略至关重要.
- 对BP-CML生物学有更深入的了解,对于开发有针对性的疗法至关重要.
更多相关视频
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.0K
10:21Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
10.0K
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
